# Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)

> **NCT01600105** · PHASE4 · COMPLETED · sponsor: **Bachir Taouli** · enrollment: 276 (actual)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DRUG:** Perfusion MRI

## Key facts

- **NCT ID:** NCT01600105
- **Lead sponsor:** Bachir Taouli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2017-07-31
- **Final completion:** 2017-07-31
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01600105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01600105, "Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01600105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*